Home / Events / Dr. Kelly Chibale from the University of Cape Town presents, “From phenotypic whole-cell hit to clinical candidate: PI4K inhibitor MMV048”
Dr. Kelly Chibale from the University of Cape Town presents, "From phenotypic whole-cell hit to clinical candidate: PI4K inhibitor MMV048" - UNC Eshelman School of Pharmacy